Atlas Trials

SIMIDIS: Azacitidine and Beta Erythropoietin Treatment in Patients With Myelodysplastic Syndrome

Clinical trial NCT00495547 · TERMINATED

Trial details

NCT number
NCT00495547
Sponsor
PETHEMA Foundation
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Myelodysplastic Syndrome
Start date
2009-02-01
Primary completion
2011-06-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.